Results 41 to 50 of about 2,672,083 (312)

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Invisible Races [PDF]

open access: yes, 2000
When a people in Zimbabwe have more of the "Jewish Priestly gene" than many Jewish Priests, what does genetics tell us?
Seth Sanders
core   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

Correction: Functional Translational Readthrough: A Systems Biology Perspective. [PDF]

open access: yesPLoS Genetics, 2016
[This corrects the article DOI: 10.1371/journal.pgen.1006196.].
PLOS Genetics Staff
doaj   +1 more source

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Genetic Samples and Genetic Philanthropy

open access: yesAMA Journal of Ethics, 2004
Genetic research is threatened by lack of samples, and public policy should be developed to encourage public participation. Virtual Mentor is a monthly bioethics journal published by the American Medical Association.
Michael E, Berens, Gary E, Marchant
openaire   +2 more sources

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Effects of Genetics and Environment on Red Flour Beetle Aggregation [PDF]

open access: yes, 2018
Red Flour Beetles are major pests for farmers storing grain and cause large profit losses. These beetles infest grain stores and their presence leads to mold growth (Baldwin).
Marshall, Jeremy, Toothaker, J. E.
core  

Sensitivity of inferences in forensic genetics to assumptions about founding genes

open access: yes, 2009
Many forensic genetics problems can be handled using structured systems of discrete variables, for which Bayesian networks offer an appealing practical modeling framework, and allow inferences to be computed by probability propagation methods.
Green, Peter J., Mortera, Julia
core   +3 more sources

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy